WebLauren White joined C4 Therapeutics in June 2024 as our Chief Financial Officer. Previously, Lauren served as vice president and global head of business planning and analysis at Novartis Institutes for BioMedical … WebC4 Therapeutics, Inc. is a Biotechnology Research, Drug Manufacturing & Research, and Biotechnology company located in Cambridge, Massachusetts with $28.00 Million in revenue and 183 employees. Find top employees, …
C4 Therapeutics Announces First Patient Dosed in Phase 1/2
WebC4 Therapeutics ® is committed to transforming the treatment of cancer, neurological, and other important diseases with novel early stage therapies that eliminate disease-causing proteins.. Our approach to medicine harnesses the innate machinery of the cell to attack disease and potentially bring deep and durable responses to patients. WebJan 10, 2024 · C4 Therapeutics Announces 2024 Key Milestones to Advance Targeted Protein Degradation Portfolio. ... – Initial Phase 1 Data for CFT7455, a Novel IKZF1/3 Degrader, Expected in 1H 2024–. – IND ... cytologisch analist
c4therapeutics.gcs-web.com
WebBoston, MA 02210 (617) 570-1000 : Jolie M. Siegel. Chief Legal Officer. C4 Therapeutics, Inc. 490 Arsenal Way, Suite 200. Watertown, MA 02472 ... as amended, C4 Therapeutics, Inc. has duly caused this Registration Statement on Form S-1 to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Watertown ... WebJan 10, 2024 · C4 Therapeutics Announces 2024 Key Milestones to Advance Targeted Protein Degradation Portfolio. ... – Initial Phase 1 Data for CFT7455, a Novel IKZF1/3 … WebC4 Therapeutics, Inc. is a Biotechnology Research, Drug Manufacturing & Research, and Biotechnology company located in Cambridge, Massachusetts with $28.00 Million in … bing chatgpt meltdown